139 related articles for article (PubMed ID: 36441437)
1. Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditions.
Liu Z; Xu Z; Gao Z; Ren Q; Chang T; Xue J; Yang H
Invest New Drugs; 2023 Feb; 41(1):60-69. PubMed ID: 36441437
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
3. A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.
Liu Y; Cheng J; Liang L; Qian W; Ou M; Zhang M; Wang Y; Wang Y; Peng K; Jia J
PLoS One; 2023; 18(4):e0284576. PubMed ID: 37083730
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wang Y; Liu Y; Tang L; Gao J; Li H; Dai X; Chen R; Wang F
Clin Pharmacol Drug Dev; 2024 Apr; 13(4):360-366. PubMed ID: 38226890
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions.
Luo HY; Yao ZJ; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Guan YQ; Gao LC
Int J Clin Pharmacol Ther; 2023 Mar; 61(3):129-138. PubMed ID: 36458443
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects.
Wang Y; Xue J; Su Z; Cui Y; Liu G; Yang W; Liu Z; Chen J; Ren Q; Yu S; Cheng Y; Zhou Y; Wang W; Chen X; Qu D; Deng Q; Zhao Y; Yang H
Expert Opin Investig Drugs; 2023 Mar; 32(3):263-270. PubMed ID: 36757390
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioequivalence of two methylprednisolone tablet formulations in healthy Chinese subjects under fasting and fed conditions.
Fan L; Zhang P; Gan C; Huang Q; Shen Z; Xiao X; Yang Y; Qiu D; Mai G; Shentu J
Int J Clin Pharmacol Ther; 2023 Jan; 61(1):37-44. PubMed ID: 36278293
[TBL] [Abstract][Full Text] [Related]
10. A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif
Liu G; Xue J; Wang Y; Liu Z; Li X; Qu D; Su Z; Xu K; Qu X; Qu Z; Sun L; Cao M; Wang Y; Chen X; Yu J; Liu L; Deng Q; Zhao Y; Zhang L; Yang H
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2585-2593. PubMed ID: 35771264
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence studies of fluvoxamine maleate tablets in healthy Chinese subjects.
She DP; He Y; Li MQ; Su L; Ren D; Huang XH; Zhang YH; Hu HT; Deng DC; Wu JL
Biomed Chromatogr; 2023 Jun; 37(6):e5613. PubMed ID: 36849133
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition
.
Park JM; Chae SI; Noh YS; Lee SJ; Shim WS; Yoon JM; Hwang SJ; Lee KT; Chung EK
Int J Clin Pharmacol Ther; 2019 Apr; 57(4):217-228. PubMed ID: 30802201
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and bioequivalence study of emtricitabine/tenofovir disoproxil fumarate tablets in healthy Chinese subjects
.
Lu C; Yang Y; Zhang Q; Zhou R; Liu Z; Hu W
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):623-632. PubMed ID: 31549623
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioequivalence of a generic empagliflozin tablet versus a brand-named product and the food effects in healthy Chinese subjects.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B
Drug Dev Ind Pharm; 2020 Sep; 46(9):1487-1494. PubMed ID: 32799565
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study.
Huang C; Yin Z; Yang Y; Mo N; Yang H; Wang Y
Drug Des Devel Ther; 2023; 17():1881-1888. PubMed ID: 37384214
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male Chinese volunteers under fasting and fed conditions.
Liu Y; Huo H; Zhao Z; Hu W; Sun Y; Tang Y
Drug Des Devel Ther; 2017; 11():3441-3448. PubMed ID: 29238169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
